Klaas Bakker

Klaas Bakker, MD PhD, currently serves as Vice President and Medicine Development Leader in Oncology R&D at GSK, responsible for evaluating and integrating new pipeline opportunities. Prior to this role, Klaas Bakker held significant positions at Oncopeptides AB, including Head of Research & Development and Chief Medical Officer, overseeing clinical development strategy and regulatory affairs in hematology. Experience also includes leadership roles at AstraZeneca, where Klaas Bakker was Vice President for Global Medical Affairs of the TAGRISSO-TDR Franchise and Executive Director for EGFR Therapies. Career beginnings involved neurosurgery training and practice at Universitair Medisch Centrum Groningen, complemented by academic credentials from the University of Groningen.